- Home
- ESTA vs KTTA Comparison
ESTA vs KTTA Comparison
Compare ESTA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESTA | KTTA |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | Costa Rica | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 5.3M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ESTA | KTTA |
|---|---|---|
| Price | $76.55 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $78.14 | $3.00 |
| AVG Volume (30 Days) | 428.2K | ★ 17.5M |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $190,973,000.00 | N/A |
| Revenue This Year | $29.25 | N/A |
| Revenue Next Year | $24.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.76 | N/A |
| 52 Week Low | $26.56 | $0.28 |
| 52 Week High | $78.24 | $3.85 |
Technical Indicators
Market Signals| Indicator | ESTA | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 66.12 | 55.73 |
| Support Level | $73.56 | $1.02 |
| Resistance Level | $77.49 | $1.21 |
| Average True Range (ATR) | 3.16 | 0.09 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 81.45 | 33.62 |
Price Performance
Historical ComparisonAbout ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).